prof. dr. ir. F. (Floris) Foijer

We are interested in the consequences of aneuploidy, an abnormal DNA content affecting 2 out of 3 cancers. By understanding how cancer cells make use of the advantages of aneuploidy and cope with the disadvantages of aneuploidy, we hope to get to therapies that can eradicate aneuploid cancers.

Member KWF Assessment board
Scientific Advisory Board Genomic Integrity Centre, Medical University Gdansk, Poland
Director UMCG Functional Genomics Centre- iPSC/CRISPR centre
Program Leader 'Regenerate' - Kolff Institute